UM: Targeting CARM1 Inhibits AML and Spares Normal Cells

UM: Targeting CARM1 Inhibits AML and Spares Normal Cells

Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have shown that inhibiting the enzyme CARM1 (also called PRMT4) dramatically slows acute myeloid leukemia (AML) progression but does not affect normal blood production.

Full Story

Related posts

UCF: Bolivian Mud Could Unlock Ancient Agriculture Secrets

A group of UCF anthropology researchers are counting on some dirty work to unlock the…

USF: What’s under the Antarctic Ice Sheet?

A unique method created by a USF associate professor to determine radiocarbon ages, will be…

USF: New Theory has fundamental implications for atmospheric and oceanic sciences

Dr. Galperin, professor of physical oceanography at USFCMS, and Dr. Semion Sukoriansky, from the Ben-Gurion…